日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dietary factors and the risk of gastric and colorectal cancers: A Mendelian randomization study

饮食因素与胃癌和结直肠癌风险:一项孟德尔随机化研究

Zhang, Yunda; Xia, Haiqun; Yang, Shengfei; Yu, Weixuan; Liu, Ming; Li, Dongwei

ASC Regulates Subcutaneous Adipose Tissue Lipogenesis and Lipolysis via p53/AMPKα Axis

ASC 通过 p53/AMPKα 轴调节皮下脂肪组织脂肪生成和脂肪分解

Hong Chen, Qilin Pei, Linfen Tao, Jing Xia, Guocai Lu, Ying Zong, Wenhua Xie, Wanqing Li, Chenglong Huang, Ting Zeng, Xinyu Yu, Weixuan Wang, Gaojun Chen, Song Yang, Rui Cheng, Xi Li

MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1

miR-142-5p通过靶向SORBS1促进乳腺癌细胞增殖、侵袭和迁移,发挥重要的调控作用。

Yu, Weixuan; Li, Dongwei; Zhang, Yunda; Li, Cheukfai; Zhang, Chuanzhao; Wang, Libin

An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer

对乳腺癌基质金属蛋白酶潜在治疗靶点的综合生物信息学分析

Xia, Haiqun; Yu, Weixuan; Liu, Ming; Li, Hong; Pang, Wei; Wang, Libin; Zhang, Yunda

Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II

新加坡稳定型或急性冠心病患者的胆固醇达标情况及降脂治疗:来自血脂异常国际研究II的结果

Poh, Kian-Keong; Chin, Chee Tang; Tong, Khim Leng; Tan, Julian Ko Beng; Lim, Jee Seong; Yu, Weixuan; Horack, Martin; Vyas, Ami; Lautsch, Dominik; Ambegaonkar, Baishali; Brudi, Philippe; Gitt, Anselm K

Direct inhibitors of InhA are active against Mycobacterium tuberculosis

InhA 的直接抑制剂对结核分枝杆菌有效

Manjunatha, Ujjini H; S Rao, Srinivasa P; Kondreddi, Ravinder Reddy; Noble, Christian G; Camacho, Luis R; Tan, Bee H; Ng, Seow H; Ng, Pearly Shuyi; Ma, Ng L; Lakshminarayana, Suresh B; Herve, Maxime; Barnes, Susan W; Yu, Weixuan; Kuhen, Kelli; Blasco, Francesca; Beer, David; Walker, John R; Tonge, Peter J; Glynne, Richard; Smith, Paul W; Diagana, Thierry T

Substituted diphenyl ethers as a novel chemotherapeutic platform against Burkholderia pseudomallei

取代二苯醚作为对抗类鼻疽伯克霍尔德菌的新型化学治疗平台

Cummings, Jason E; Beaupre, Adam J; Knudson, Susan E; Liu, Nina; Yu, Weixuan; Neckles, Carla; Wang, Hui; Khanna, Avinash; Bommineni, Gopal R; Trunck, Lily A; Schweizer, Herbert P; Tonge, Peter J; Slayden, Richard A

Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor.

基于临床相关的烯酰-酰基载体蛋白(ACP)还原酶抑制剂的广谱抗菌活性的合理设计

Schiebel Johannes, Chang Andrew, Shah Sonam, Lu Yang, Liu Li, Pan Pan, Hirschbeck Maria W, Tareilus Mona, Eltschkner Sandra, Yu Weixuan, Cummings Jason E, Knudson Susan E, Bommineni Gopal R, Walker Stephen G, Slayden Richard A, Sotriffer Christoph A, Tonge Peter J, Kisker Caroline

A structural and energetic model for the slow-onset inhibition of the Mycobacterium tuberculosis enoyl-ACP reductase InhA

结核分枝杆菌烯酰-ACP还原酶InhA缓慢抑制的结构和能量模型

Li, Huei-Jiun; Lai, Cheng-Tsung; Pan, Pan; Yu, Weixuan; Liu, Nina; Bommineni, Gopal R; Garcia-Diaz, Miguel; Simmerling, Carlos; Tonge, Peter J

Rational optimization of drug-target residence time: insights from inhibitor binding to the Staphylococcus aureus FabI enzyme-product complex.

合理优化药物靶点停留时间:从抑制剂与金黄色葡萄球菌 FabI 酶-产物复合物的结合中获得的启示

Chang Andrew, Schiebel Johannes, Yu Weixuan, Bommineni Gopal R, Pan Pan, Baxter Michael V, Khanna Avinash, Sotriffer Christoph A, Kisker Caroline, Tonge Peter J